Skip to content

A Clinical Study on the Effect of 2 Vaitarana Basti Therapy in Sciatica

AN OPEN LABEL RANDOMIZED COMPARATIVE CLINICAL TRIAL ON THE EFFECTIVENESS OF DIFFERENT COMBINATION OF VAITARANA BASTI IN GRIDHRASI(SCIATICA). - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104503
Enrollment
50
Registered
2026-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

None listed

Sponsors

Dr Chandana N Nadig
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with the Lakshana of Gridhrasi Sciatica 2. Age 30-50 years 3. Positive SLR Test and Lasegues sign. 4. Patient fit for Basti Chikitsa. 5. Patients with recent onset to less than 3 years history of Gridhrasi. 6. Patient who are willing to sign a consent for the Treatment.

Exclusion criteria

Exclusion criteria: Patients with Diabetes Mellitus. Patients with history of hypertension, cardiac Issues or other systemic Pathologies. Patient with Spinal Tuberculosis, Fractures, Tumors, or other severe deformities. Patient with Progressive Neurological deficits or those require immediate surgical intervention and Post-surgical spinal diseases. Auto-immune Diseases. Pregnant and Lactating women. Patient unfit for Basti chikitsa.

Design outcomes

Primary

MeasureTime frame
Assessment will be based on the symptoms like radiating pain from Sphik pradesha to Kati, Uru, Janu, Jangha and Pada, Toda, Stambha, Spandana is assessed by clinical Gradings & Reduction in the Pain through VAS scale. Improvement in Objective parameters through SLR test, Lumbar spine mobility (LSM) test, Lasegue s sign, The low back outcome score (LBOS) scale of Greenough and Fraser. Timepoint: Before treatment 1st assessment- 0th day After treatment 2nd assessment- 8th day 1st follow-up Final assessment- 24th day

Secondary

MeasureTime frame
Improvement in the functionality is assessed through Oswestry Disability Index (Questionnaire s method)Timepoint: Before treatment 1st assessment- 0th day After treatment 2nd assessment- 8th day 1st follow-up Final assessment- 24th day

Countries

India

Contacts

Public ContactDr Prashanth Kumar

SDM Institute of Ayurveda and Hospital

drpknrao@gmail.com9844708874

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026